| Website | knoppneuroscience... |
| Category | BioTech |
| Phone | 412-488-1776 |
| Employees |
| TOTAL | $20M |
| VENTURE FUNDING TOTAL | $20M |
| Series A, 2006 LaunchCyte Kramer Capital Partners Saturn Venture Partners | $10M |
| Series B, 1/08 Saturn Venture Partners Kramer Capital Partners LaunchCyte | $10M |
Knopp Neurosciences is a drug discovery and development company focused on delivering breakthrough treatments in neurological disorders through innovation, experience and partnership. Knopp’s lead compound, KNS-760704, is currently in clinical development for amyotrophic lateral sclerosis, with additional indications under investigation.
